Close Menu

NEW YORK (360Dx) – Opko Health today priced its public offering of $200 million in convertible senior notes.

The notes will be senior unsecured obligations of the company and pay interest semiannually in arrears at a rate of 4.5 percent per year. The notes , which will mature on Feb. 15, 2025, will be convertible into, at the company's decision, cash, shares of the company's common stock, or a combination of both.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.